Buchanan TR, Zamorano AS, Massad LS, et al. - After surgical management for high-grade vulvar intraepithelial neoplasia (VIN) and vulvar cancer, researchers estimated how often abnormal surveillance cytology leads to high-grade dysplasia and if previous hysterectomy lowers this risk. Between 2006 and 2014, women who had surgery for high-grade VIN or vulvar cancer were identified; it included patients who had the previous hysterectomy for any indication. Three hundred two women underwent surveillance with cytologic screening following vulvar surgery including 99 women with prior hysterectomy during a median follow-up of 72 months. According to findings, women who are surgically treated for VIN/vulvar cancer have an 8% risk from surveillance screening for at least high-grade dysplasia; prior hysterectomy does not lessen the risk. Surveillance cytology screening following treatment for at least 6–12 months was recommended.